ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 242 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $959,824 | -38.3% | 73,046 | -40.9% | 0.01% | -33.3% |
| Q2 2023 | $1,556,150 | +3.1% | 123,504 | +6.8% | 0.01% | -7.7% |
| Q1 2023 | $1,509,715 | +73080.6% | 115,687 | -1.1% | 0.01% | -23.5% |
| Q4 2022 | $2,063 | -99.9% | 116,933 | +15.8% | 0.02% | +13.3% |
| Q3 2022 | $1,537,000 | -2.0% | 100,946 | -4.6% | 0.02% | -11.8% |
| Q2 2022 | $1,568,000 | -34.1% | 105,764 | +0.1% | 0.02% | -26.1% |
| Q1 2022 | $2,380,000 | +39.3% | 105,669 | +14.1% | 0.02% | +27.8% |
| Q4 2021 | $1,709,000 | +34.9% | 92,640 | -2.3% | 0.02% | +20.0% |
| Q3 2021 | $1,267,000 | -36.8% | 94,785 | -12.5% | 0.02% | -31.8% |
| Q2 2021 | $2,005,000 | +23.6% | 108,332 | +0.3% | 0.02% | +10.0% |
| Q1 2021 | $1,622,000 | -8.2% | 107,993 | -11.8% | 0.02% | -20.0% |
| Q4 2020 | $1,767,000 | +71.7% | 122,381 | -3.2% | 0.02% | +25.0% |
| Q3 2020 | $1,029,000 | +85.7% | 126,460 | +54.6% | 0.02% | +100.0% |
| Q2 2020 | $554,000 | +105.9% | 81,824 | +114.2% | 0.01% | +66.7% |
| Q1 2020 | $269,000 | -4.3% | 38,199 | +33.4% | 0.01% | +20.0% |
| Q4 2019 | $281,000 | -12.7% | 28,638 | -2.4% | 0.01% | -16.7% |
| Q3 2019 | $322,000 | -5.6% | 29,342 | +0.0% | 0.01% | 0.0% |
| Q2 2019 | $341,000 | +18.4% | 29,329 | -2.8% | 0.01% | +20.0% |
| Q1 2019 | $288,000 | -2.7% | 30,184 | -1.5% | 0.01% | -16.7% |
| Q4 2018 | $296,000 | -41.5% | 30,658 | -13.6% | 0.01% | -14.3% |
| Q3 2018 | $506,000 | -12.2% | 35,476 | -26.1% | 0.01% | -12.5% |
| Q2 2018 | $576,000 | -4.3% | 48,033 | -1.5% | 0.01% | 0.0% |
| Q1 2018 | $602,000 | +56.8% | 48,762 | +84.8% | 0.01% | +60.0% |
| Q4 2017 | $384,000 | +2.4% | 26,391 | +0.2% | 0.01% | -16.7% |
| Q3 2017 | $375,000 | +10.9% | 26,347 | -0.5% | 0.01% | +20.0% |
| Q2 2017 | $338,000 | +1.2% | 26,484 | +0.4% | 0.01% | -16.7% |
| Q1 2017 | $334,000 | +19.3% | 26,369 | -3.8% | 0.01% | +20.0% |
| Q4 2016 | $280,000 | -22.9% | 27,403 | -0.7% | 0.01% | -28.6% |
| Q3 2016 | $363,000 | -20.6% | 27,595 | -23.4% | 0.01% | -12.5% |
| Q2 2016 | $457,000 | +2.2% | 36,006 | +6.4% | 0.01% | -20.0% |
| Q1 2016 | $447,000 | -47.0% | 33,846 | -38.2% | 0.01% | -44.4% |
| Q4 2015 | $843,000 | +24.7% | 54,801 | +0.5% | 0.02% | +12.5% |
| Q3 2015 | $676,000 | +0.6% | 54,539 | +11.0% | 0.02% | +33.3% |
| Q2 2015 | $672,000 | +26.8% | 49,125 | +10.9% | 0.01% | +33.3% |
| Q1 2015 | $530,000 | +14.2% | 44,287 | +21.8% | 0.01% | +28.6% |
| Q4 2014 | $464,000 | +47.3% | 36,349 | +54.7% | 0.01% | +40.0% |
| Q3 2014 | $315,000 | -11.5% | 23,503 | +5.8% | 0.01% | 0.0% |
| Q2 2014 | $356,000 | -48.3% | 22,210 | -41.8% | 0.01% | -54.5% |
| Q1 2014 | $688,000 | +99.4% | 38,135 | +71.1% | 0.01% | +120.0% |
| Q4 2013 | $345,000 | +3.0% | 22,290 | -0.9% | 0.01% | -16.7% |
| Q3 2013 | $335,000 | +2.8% | 22,495 | -10.8% | 0.01% | 0.0% |
| Q2 2013 | $326,000 | – | 25,225 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |